Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Eugenio Piro"'
Publikováno v:
Chemotherapy. 63:107-110
Iron overload (IOL) due to transfusion-dependent anemia is a serious adverse effect in patients with myelofibrosis (MF). Recent studies have shown that the oral iron chelator deferasirox may prevent multiple organ damage due to IOL in MF. However, it
Autor:
Diana Giannarelli, Rosanna Mirabelli, Luciano Levato, Stefano Molica, Eugenio Piro, Mirella Lentini, Domenico Levato
Publikováno v:
Leukemia & Lymphoma. 60:845-847
At the time of diagnosis of chronic lymphocytic leukemia (CLL) median age of patients is 72 years and the incidence of this hematologic malignancy increases steadily with age [1,2]. Therefore, due ...
Autor:
Vittorio Emanuele Muccio, Milena, Gilestro, Elona, Saraci, Andrea, Capra, Costa, Alessandro, Marina, Ruggeri, Simona, Caltagirone, Daniela, Oddolo, Chiara, Mussatto, Pellegrino, Musto, Lucia, Pantani, Vincenzo, Pavone, Sonia, Ronconi, Iolanda Donatella Vincelli, Anna Maria Cafro, Claudia, Cellini, Innao, Vanessa, Eugenio, Piro, Francesca, Gay, Mario, Boccadoro, Paola, Omedé
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3978::a1e1f7c15de1eb3d3d89ea7adcabb49a
http://hdl.handle.net/11570/3171806
http://hdl.handle.net/11570/3171806
Autor:
Vittorio Emanuele Muccio, Milena Gilestro, Elona Saraci, Andrea Capra, Alessandro Costa, Marina Ruggeri, Simona Caltagirone, Daniela Oddolo, Chiara Mussatto, Pellegrino Musto, Lucia Pantani, Vincenzo Pavone, Sonia Ronconi, Iolanda Donatella Vincelli, Anna Maria Cafro, Claudia Cellini, Vanessa Innao, Eugenio Piro, Francesca Gay, Mario Boccadoro, Paola Omedé
Publikováno v:
Blood. 134:4357-4357
Background: In multiple myeloma (MM), different clinical parameters and molecular prognostic factors can predict disease course and response to therapy. The classification of myeloma patients includes laboratory parameters associated with higher tumo
Autor:
Massimo Martino, Francesca Ronco, Caterina Musolino, Roberta Fedele, Caterina Alati, Fortunato Morabito, Giuseppa Penna, Tiziana Moscato, Santo Neri, Massimo Gentile, Eugenio Piro, Iolanda Vincelli, Anna Grazia Recchia, Stefano Molica
Publikováno v:
Cytotherapy. 17:1485-1493
Background aims Filgrastim and lenograstim are the standard granulocyte colony-stimulating factor (G-CSF) agents for peripheral blood stem cell mobilization (PBSC) in patients who undergo autologous stem cell transplantation. Methods To assess whethe
Autor:
Tullia Prantera, Francesco Baudi, Iole Cucinotto, Pietro Hiram Guzzi, Mario Cannataro, Marco Rossi, Maria Teresa Di Martino, Mariamena Arbitrio, Eugenio Piro, Emanuela Leone, Pierangelo Veltri, Pierosandro Tagliaferri, Teresa Calimeri, Pierfrancesco Tassone
Publikováno v:
British Journal of Haematology
The aminobisphosphonate zoledronic acid (ZA) is the most important antiresorptive agent for the treatment of multiple myeloma (MM)-related bone disease (BD). Osteonecrosis of the jaw (ONJ) is an important complication of ZA-treated MM patients (Vannu
Autor:
Marco Rossi, Paola Neri, Nizar J. Bahlis, Umberto Foresta, Eugenio Piro, Filippo Causa, Pierosandro Tagliaferri, Felicetto Ferrara, Nikhil C. Munshi, Edmondo Battista, Pierfrancesco Tassone, Francesco Conforti, M T Di Martino, Teresa Calimeri, Kenneth C. Anderson, Andrea Amorosi
Publikováno v:
Leukemia
Multiple myeloma (MM) cells home to the bone marrow (BM) and adhere to extracellular matrix (ECM) proteins and to bone marrow stromal cells (BMSCs). The close cross talk between MM cells and cells of the non-tumor compartment within the BM has a key
Autor:
Caterina Musolino, Giuseppe Irrera, Massimo Martino, Fortunato Morabito, Caterina Stelitano, Giuseppe Console, Pasquale Iacopino, Vincenzo Callea, Eugenio Piro, Eugenia Quartarone, Maura Brugiatelli, Giulia Praticò
Publikováno v:
American Journal of Hematology. 81:973-978
The recent development of reduced intensity conditioning and allotransplantation (RICT) has opened a new way to assure engraftment of donor cells while reducing early transplant-related mortality. We evaluated the combination of high-dose therapy and
Autor:
Giuseppe Alberto Gallo, Tiziana Moscato, Fortunato Morabito, Giuseppe Irrera, Caterina Musolino, Maurizio Postorino, Francesca Ronco, Giuseppe Messina, Santo Neri, Giuseppe Console, Roberta Fedele, Eugenio Piro, Massimo Martino, Iolanda Vincelli, Stefano Molica, Carla Mazzone, Giuseppa Penna, Massimo Gentile, Caterina Alati, Renza Monteleone
Publikováno v:
Clinical lymphoma, myelomaleukemia. 14(2)
Background The aim of this study was to investigate the correlation between the long-term prognosis of multiple myeloma (MM) and the quality of response to therapy in a cohort of 173 patients treated with high-dose melphalan (HDM) and autologous tran
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(26)